Skip to main content
Erschienen in: World Journal of Urology 4/2015

01.04.2015 | Topic Paper

Thulium laser versus standard transurethral resection of the prostate for benign prostatic obstruction: a systematic review and meta-analysis

verfasst von: Yiping Zhu, Jian Zhuo, Dongliang Xu, Shujie Xia, Thomas R. W. Herrmann

Erschienen in: World Journal of Urology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To assess the efficacy and safety of thulium laser versus standard transurethral resection of the prostate (TURP) for treating patients with benign prostatic obstruction.

Methods

A systematic search of the electronic databases, including Medline, Embase, Web of Science, and The Cochrane Library, was performed up to February 1, 2014. The pooled estimates of demographic and clinical baseline characteristics, perioperative variables, complications, and postoperative efficacy including International Prostate Symptom Score (IPSS), quality of life (QoL), maximum flow rate (Qmax), and postvoid residual (PVR) were calculated.

Results

Seven trials assessing thulium laser versus standard TURP were considered suitable for meta-analysis including four randomized controlled trials (RCTs) and three non-RCTs. Compared with TURP, although thulium laser prostatectomy (TmLRP) needed a longer operative time [weighted mean difference (WMD) 8.18 min; 95 % confidence interval (CI) 1.60–14.75; P = 0.01], patients having TmLRP might benefit from significantly less serum sodium decreased (−3.73 mmol/L; 95 % CI −4.41 to −3.05; P < 0.001), shorter time of catheterization (WMD −1.29 days; 95 % CI −1.95 to −0.63; P < 0.001), shorter length of hospital stay (WMD −1.83 days; 95 % CI −3.10 to −0.57; P = 0.005), and less transfusion (odds ratio 0.09; 95 % CI 0.02–0.41; P = 0.002). During the 1, 3, and, 12 months of postoperative follow-up, the procedures did not demonstrate a significant difference in IPSS, QoL, Qmax, and PVR.

Conclusions

TmLRP had a similar efficacy to standard TURP in terms of IPSS, QoL, Qmax, and PVR, and offered several advantages over TURP in terms of blood transfusion, serum sodium decreased, catheterization time, and hospital stay, while TURP was superior in terms of operation duration. Well-designed multicentric/international RCTs with long-term follow-up are still needed.
Literatur
1.
Zurück zum Zitat Bushman W (2009) Etiology, epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am 36(4):403–415CrossRefPubMed Bushman W (2009) Etiology, epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am 36(4):403–415CrossRefPubMed
2.
Zurück zum Zitat Zhuo J, Xia SJ (2013) Is it necessary and feasible to increase the efficiency of 2-µm thulium laser resection of the prostate? Asian J Androl 15(4):453–454CrossRefPubMedCentralPubMed Zhuo J, Xia SJ (2013) Is it necessary and feasible to increase the efficiency of 2-µm thulium laser resection of the prostate? Asian J Androl 15(4):453–454CrossRefPubMedCentralPubMed
3.
Zurück zum Zitat Zhuo J, Wei HB et al (2014) Two-micrometer thulium laser resection of the prostate-tangerine technique for patients with acute urinary retention. Lasers Med Sci 29(3):1093–1098CrossRefPubMed Zhuo J, Wei HB et al (2014) Two-micrometer thulium laser resection of the prostate-tangerine technique for patients with acute urinary retention. Lasers Med Sci 29(3):1093–1098CrossRefPubMed
4.
Zurück zum Zitat Fried NM (2005) High-power laser vaporization of the canine prostate using a 110 W Thulium fiber laser at 1.91 micron. Lasers Surg Med 36(1):52–56CrossRefPubMed Fried NM (2005) High-power laser vaporization of the canine prostate using a 110 W Thulium fiber laser at 1.91 micron. Lasers Surg Med 36(1):52–56CrossRefPubMed
5.
Zurück zum Zitat Fried NM, Murray KE (2005) High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol 19:25–31CrossRefPubMed Fried NM, Murray KE (2005) High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol 19:25–31CrossRefPubMed
6.
Zurück zum Zitat Xia SJ, Zhang YN, Lu J et al (2005) Thulium laser resection of prostate-tangerine technique in treatment of benign prostate hyperplasia. Nat Med J China 85(45):3225–3228 Xia SJ, Zhang YN, Lu J et al (2005) Thulium laser resection of prostate-tangerine technique in treatment of benign prostate hyperplasia. Nat Med J China 85(45):3225–3228
7.
Zurück zum Zitat Xia SJ (2009) Two-micron (thulium) laser resection of the prostate-tangerine technique: a new method for BPH treatment. Asian J Androl 11:277–281CrossRefPubMedCentralPubMed Xia SJ (2009) Two-micron (thulium) laser resection of the prostate-tangerine technique: a new method for BPH treatment. Asian J Androl 11:277–281CrossRefPubMedCentralPubMed
8.
Zurück zum Zitat Xia SJ, Zhuo J, Sun XW et al (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53(2):382–389CrossRefPubMed Xia SJ, Zhuo J, Sun XW et al (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53(2):382–389CrossRefPubMed
9.
Zurück zum Zitat Bach T, Xia SJ, Yang Y et al (2010) Thulium:YAG 2 lm cw laser prostatectomy: where do we stand? World J Urol 28(2):163–168CrossRefPubMed Bach T, Xia SJ, Yang Y et al (2010) Thulium:YAG 2 lm cw laser prostatectomy: where do we stand? World J Urol 28(2):163–168CrossRefPubMed
10.
Zurück zum Zitat Wei HB, Shao Y, Sun F et al (2014) Thulium laser resection versus plasmakinetic resection of prostates larger than 80 ml. World J Urol 32(4):1077–1085 Wei HB, Shao Y, Sun F et al (2014) Thulium laser resection versus plasmakinetic resection of prostates larger than 80 ml. World J Urol 32(4):1077–1085
11.
Zurück zum Zitat Wei HB, Zhuo J, Sun XW et al (2014) Safety and efficiency of thulium laser prostate resection for the treatment of benign prostatic hyperplasia in large prostates. Lasers Med Sci 29(3):957–963CrossRefPubMed Wei HB, Zhuo J, Sun XW et al (2014) Safety and efficiency of thulium laser prostate resection for the treatment of benign prostatic hyperplasia in large prostates. Lasers Med Sci 29(3):957–963CrossRefPubMed
12.
Zurück zum Zitat Cui D, Sun F, Zhuo J et al (2014) A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results. World J Urol 32(3):683–689CrossRefPubMed Cui D, Sun F, Zhuo J et al (2014) A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results. World J Urol 32(3):683–689CrossRefPubMed
13.
Zurück zum Zitat Fu WJ, Zhang X, Yang Y et al (2010) Comparison of 2-microm continuous wave laser vaporesection of the prostate and transurethral resection of the prostate: a prospective nonrandomized trial with 1-year follow-up. Urology 75(1):194–199CrossRefPubMed Fu WJ, Zhang X, Yang Y et al (2010) Comparison of 2-microm continuous wave laser vaporesection of the prostate and transurethral resection of the prostate: a prospective nonrandomized trial with 1-year follow-up. Urology 75(1):194–199CrossRefPubMed
14.
Zurück zum Zitat Paweł Świniarski P, Stępień S, Dudzic W et al (2012) Thulium laser enucleation of the prostate (TmLEP) vs. transurethral resection of the prostate (TURP): evaluation of early results. Cent Eur J Urol 65(3):130–134 Paweł Świniarski P, Stępień S, Dudzic W et al (2012) Thulium laser enucleation of the prostate (TmLEP) vs. transurethral resection of the prostate (TURP): evaluation of early results. Cent Eur J Urol 65(3):130–134
15.
Zurück zum Zitat Shao JK, Wang YB, Lü YA, Li XD (2012) Comparison of 2 µm continuous-wave laser enucleation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia. Zhonghua Wai Ke Za Zhi. 50(2):131–134PubMed Shao JK, Wang YB, Lü YA, Li XD (2012) Comparison of 2 µm continuous-wave laser enucleation of the prostate and transurethral resection of the prostate for benign prostatic hyperplasia. Zhonghua Wai Ke Za Zhi. 50(2):131–134PubMed
16.
Zurück zum Zitat Yan H, Ou TW, Chen L et al (2013) Thulium laser vaporesection versus standard transurethral resection of the prostate: a randomized trial with transpulmonary thermodilution hemodynamic monitoring. Int J Urol 20(5):507–512CrossRefPubMed Yan H, Ou TW, Chen L et al (2013) Thulium laser vaporesection versus standard transurethral resection of the prostate: a randomized trial with transpulmonary thermodilution hemodynamic monitoring. Int J Urol 20(5):507–512CrossRefPubMed
17.
Zurück zum Zitat Zhuo J, Xia SJ, Liu HT et al (2007) A comparative study of thulium laser resection of the prostate-Tangerine technique and transurethral resection of the prostate for the treatment of benign prostatic hyperplasia. Chin J Urol 01:38–41 Zhuo J, Xia SJ, Liu HT et al (2007) A comparative study of thulium laser resection of the prostate-Tangerine technique and transurethral resection of the prostate for the treatment of benign prostatic hyperplasia. Chin J Urol 01:38–41
19.
Zurück zum Zitat Clarke M, Horton R (2001) Bringing it all together: lancet-Cochrane collaborate on systematic reviews. Lancet 357:1728CrossRefPubMed Clarke M, Horton R (2001) Bringing it all together: lancet-Cochrane collaborate on systematic reviews. Lancet 357:1728CrossRefPubMed
20.
Zurück zum Zitat Xu Y, Sun DC, Yang Y et al (2013) 5-year follow-up to transurethral vaporesection of the prostate using the 2 micron continuous wave laser for the treatment of benign prostatic hyperplasia. Zhonghua Wai Ke Za Zhi. 51(2):119–122PubMed Xu Y, Sun DC, Yang Y et al (2013) 5-year follow-up to transurethral vaporesection of the prostate using the 2 micron continuous wave laser for the treatment of benign prostatic hyperplasia. Zhonghua Wai Ke Za Zhi. 51(2):119–122PubMed
Metadaten
Titel
Thulium laser versus standard transurethral resection of the prostate for benign prostatic obstruction: a systematic review and meta-analysis
verfasst von
Yiping Zhu
Jian Zhuo
Dongliang Xu
Shujie Xia
Thomas R. W. Herrmann
Publikationsdatum
01.04.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 4/2015
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-014-1410-6

Weitere Artikel der Ausgabe 4/2015

World Journal of Urology 4/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.